TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic lymphocytic leukemia

Leuk Res. 2013 Jun;37(6):665-70. doi: 10.1016/j.leukres.2013.01.005. Epub 2013 Feb 21.

Abstract

This prospective study was planned to determine the intercourse between translationally controlled tumor protein (TCTP)/histamine releasing factor (HRF)/histamine pathway and angiogenesis in chronic lymphocytic leukemia (CLL). A total of 153 CLL patients were included. Serum histamine levels were higher in CLL patients. A positive correlation was found between microvessel density (MVD)-mast cell (MC) count; MVD-TCTP/HRF and MC count-TCTP/HRF. Microvessel density, MC and ZAP 70 were significantly higher in TCTP/HRF-positive group. Time to first treatment was shorter in patients with increased MVD and TCTP/HRF. Further data is essential to ascertain the role of TCTP/HRF pathway in tumor angiogenesis and CLL prognosis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism
  • Biomarkers, Tumor / physiology*
  • Case-Control Studies
  • Disease Progression
  • Feasibility Studies
  • Female
  • Histamine / blood
  • Histamine / metabolism
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / etiology
  • Neovascularization, Pathologic / metabolism*
  • Prognosis
  • Signal Transduction / physiology
  • Tumor Protein, Translationally-Controlled 1

Substances

  • Biomarkers, Tumor
  • TPT1 protein, human
  • Tumor Protein, Translationally-Controlled 1
  • Histamine